The use of artificial intelligence (AI) and big data in medicine has increased in recent years. Indeed, the use of AI in mobile health (mHealth) apps could considerably assist both individuals and health care professionals in the prevention and management of chronic diseases, in a person-centered manner. Nonetheless, there are several challenges that must be overcome to provide high-quality, usable, and effective mHealth apps. Here, we review the rationale and guidelines for the implementation of mHealth apps and the challenges regarding quality, usability, and user engagement and behavior change, with a special focus on the prevention and management of noncommunicable diseases. We suggest that a cocreation-based framework is the best method to address these challenges. Finally, we describe the current and future roles of AI in improving personalized medicine and provide recommendations for developing AI-based mHealth apps. We conclude that the implementation of AI and mHealth apps for routine clinical practice and remote health care will not be feasible until we overcome the main challenges regarding data privacy and security, quality assessment, and the reproducibility and uncertainty of AI results. Moreover, there is a lack of both standardized methods to measure the clinical outcomes of mHealth apps and techniques to encourage user engagement and behavior changes in the long term. We expect that in the near future, these obstacles will be overcome and that the ongoing European project, Watching the risk factors (WARIFA), will provide considerable advances in the implementation of AI-based mHealth apps for disease prevention and health promotion.
Well-annotated datasets are fundamental for developing robust artificial intelligence models, particularly in medical fields. Many existing skin lesion datasets have limitations in image diversity (including only clinical or dermoscopic images) or metadata, which hinder their utility for mimicking real-world clinical practice. The purpose of the MCR-SL dataset is to introduce a new, meticulously curated dataset that addresses these limitations. The MCR-SL dataset was collected from 60 subjects at the University Hospital of North Norway and comprises 779 clinical images and 1352 dermoscopic images of 240 unique lesions. The lesion types included are nevus, seborrheic keratosis, basal cell carcinoma, actinic keratosis, atypical nevus, melanoma, squamous cell carcinoma, angioma, and dermatofibroma. Labels were established by combining the consensus of a panel of four dermatologists with histopathology reports for the 29 excised lesions, with the latter serving as the gold standard. The resulting dataset provides a comprehensive resource with clinical and dermoscopic images and rich clinical context, ensuring a high level of clinical relevance, surpassing many existing resources in that matter. The MCR-SL dataset provides a holistic and reliable foundation for validating artificial intelligence models, enabling a more nuanced and clinically relevant approach to automated skin lesion diagnosis that mirrors real-world clinical practice.
The early detection of precancerous cervical lesions is essential to improve patient treatment and prognosis. Hyperspectral (HS) imaging (HSI) has demonstrated a high potential to become a new non-invasive and label-free imaging technique in the medical field for performing quick diagnosis of different diseases. This study presents the research and development process to integrate and characterize a KURIOS-XE2 filter (Thorlabs, Inc., NJ, USA), based in a liquid crystal tunable filter (LCTF) technology, into an existing colposcope (C5, OPTOMIC, Spain). The main goal was to capture spectral information in the near infrared range (650 to 1100nm) by using a monochrome camera and acquiring 90 spectral wavelengths with a spectral resolution of 5nm. Two different integration strategies were studied: i) filtering the emitted light by the sensor and ii) filtering the received light by the sensor, evaluating their respective benefits and limitations. Furthermore, a custom software was developed for HS image acquisition, integrating a variable acquisition time per wavelength, which allows improving the signal-to-noise ratio at wavelengths where the system presents lower quantum efficiency. The proposed system simplifies the adaptation of existing optical systems to HSI technology, improving the signal-to-noise ratio in the studied spectral range respect to other approaches. The results were compared against a previous custom implementation based on a Snapscan camera (IMEC, Belgium), covering the visual and near infrared and highlighting the advantages and limitations of both technologies for the development of a HS colposcope system targeting early detection of precancerous cervical lesions during routine clinical practice.
UNSTRUCTURED The use of artificial intelligence (AI) and big data in medicine has increased in recent years. Indeed, the use of AI in mobile health (mHealth) apps could considerably assist both individuals and health care professionals in the prevention and management of chronic diseases, in a person-centered manner. Nonetheless, there are several challenges that must be overcome to provide high-quality, usable, and effective mHealth apps. Here, we review the rationale and guidelines for the implementation of mHealth apps and the challenges regarding quality, usability, and user engagement and behavior change, with a special focus on the prevention and management of noncommunicable diseases. We suggest that a cocreation-based framework is the best method to address these challenges. Finally, we describe the current and future roles of AI in improving personalized medicine and provide recommendations for developing AI-based mHealth apps. We conclude that the implementation of AI and mHealth apps for routine clinical practice and remote health care will not be feasible until we overcome the main challenges regarding data privacy and security, quality assessment, and the reproducibility and uncertainty of AI results. Moreover, there is a lack of both standardized methods to measure the clinical outcomes of mHealth apps and techniques to encourage user engagement and behavior changes in the long term. We expect that in the near future, these obstacles will be overcome and that the ongoing European project, Watching the risk factors (WARIFA), will provide considerable advances in the implementation of AI-based mHealth apps for disease prevention and health promotion.
Well-annotated datasets are fundamental for developing robust artificial intelligence models, particularly in medical fields. Many existing skin lesion datasets have limitations in image diversity (including only clinical or dermoscopic images) or metadata, which hinder their utility for mimicking real-world clinical practice. The purpose of the MCR-SL dataset is to introduce a new, meticulously curated dataset that addresses these limitations. The MCR-SL dataset was collected from 60 subjects at the University Hospital of North Norway and comprises 779 clinical images and 1,352 dermoscopic images of 240 unique lesions. The lesion types included are nevus, seborrheic keratosis, basal cell carcinoma, actinic keratosis, atypical nevus, melanoma, squamous cell carcinoma, angioma, and dermatofibroma. Labels were established by combining the consensus of a panel of four dermatologists with histopathology reports for the 29 excised lesions, with the latter serving as the gold standard. The resulting dataset provides a comprehensive resource with clinical and dermoscopic images and rich clinical context, ensuring a high level of clinical relevance, surpassing many existing resources in that matter. The MCR-SL dataset provides a holistic and reliable foundation for validating artificial intelligence models, enabling a more nuanced and clinically relevant approach to automated skin lesion diagnosis that mirrors real-world clinical practice.